GKCC SCHEDULE 13D

Company

Immix Biopharma, Inc.

Filed

August 30, 2023

Accession Number

0001068238-23-000182

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →